| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of US$ 200/kg
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| product name | Cilostazol |
| CAS NO. | 73963-72-1 |
| Specification | 99% |
| Appearance | White powder |
| packing | 1kg/bag,25kgs/drum |
| MOQ | 1KG |
Cilostazol is an organic compound with the chemical formula C20H27N5O2, mainly used as an antiplatelet aggregation drug.
| Item | Specification | Test result |
| Appearance | white powder | Conforms |
| Assay | 99% | Conforms |
| Heavy metal | ≤10ppm | Conforms |
| Lead | ≤2.0ppm | Conforms |
| As | ≤2.0ppm | Conforms |
| Ca | ≤1.0ppm | Conforms |
| Me | ≤0.1ppm | Conforms |
| Total aerobic microbial count | ≤1000CFU/g | Conforms |
| Total moulds&yeast count | ≤100CFU/g | Conforms |
| Enterobacterial | ≤10MPN/g | Conforms |
| Salmonella | N.D/25g | Conforms |
| Escherichia coli | N.D/10g | Conforms |
| Staphylococcus aureus | N.D/10g | Conforms |
| Pseudomonas aeruginosa | N.D/10g | Conforms |
| Conclusion: Conform with specification. | ||
Cilostazol has vasodilatory and antiplatelet functions. It inhibits the activity of phosphodiesterase in platelets and vascular smooth muscle, thereby increasing the cAMP concentration in platelets and smooth muscle, exerting antiplatelet and vasodilatory effects. It inhibits the initial and secondary aggregation and release reactions of platelets induced by ADP, collagen and arachidonic acid, and has a significant antithrombotic effect on the model of cerebral circulation and peripheral circulation disorders caused by collagen, ADP, arachidonic acid and sodium laurate. It can be used to treat chronic arterial occlusive disease caused by atherosclerosis, large arteritis, thromboangiitis obliterans, diabetes, etc.
){kind=link}